Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty

G A Ferns1, L A Forster, J C Williams

  • 1Department of Clinical Biochemistry, The Royal Surrey County Hospital, Guildford, UK. g.ferns@surrey.ac.uk

Insights

Vitamin E supplementation may reduce platelet and endothelial activation during percutaneous transluminal coronary angioplasty (PTCA). This study found vitamin E limited increases in soluble P-selectin and intercellular adhesion molecule-1 levels post-PTCA compared to placebo.

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Science
  • Biochemistry

Background:

  • Soluble adhesion molecules, including P-selectin (sP-selectin) and intercellular adhesion molecule-1 (sICAM-1), are elevated in atherosclerosis and after percutaneous transluminal coronary angioplasty (PTCA).
  • These molecules originate from platelets and endothelial cells, indicating cellular activation during vascular procedures.

Purpose of the Study:

  • To investigate the effect of vitamin E supplementation on plasma levels of sICAM-1 and sP-selectin before and after PTCA.
  • To determine if vitamin E can mitigate the increase in these soluble adhesion molecules typically observed post-PTCA.

Main Methods:

  • A randomized controlled trial involving patients undergoing PTCA, pre-treated with either vitamin E (800 IU/day) or placebo for one month.
  • Plasma levels of sICAM-1, sP-selectin, and alpha-tocopherol were measured using enzyme-linked immunosorbent assay (ELISA) immediately before and after PTCA.
  • Statistical analysis was performed to compare changes in adhesion molecule concentrations between the vitamin E and placebo groups.

Main Results:

  • Vitamin E supplementation significantly increased plasma alpha-tocopherol concentrations.
  • In the vitamin E group, there were no significant increases in plasma sP-selectin or sICAM-1 levels post-PTCA.
  • The placebo group showed a significant increase in sP-selectin post-PTCA, and this increase was significantly greater than in the vitamin E group.

Conclusions:

  • Vitamin E supplementation appears to limit platelet and endothelial activation during PTCA, as evidenced by blunted increases in sP-selectin.
  • These findings suggest a potential role for vitamin E in managing vascular inflammation associated with interventional cardiology procedures.